Literature DB >> 7041660

Identifying the health risks from very low-dose sparsely ionizing radiation.

N A Dreyer, E Friedlander.   

Abstract

The health risks from low-dose sparsely ionizing (low-LET) radiation have been the subject of continued debate. At present, quantitative estimates of risk are extremely uncertain due to the controversy surrounding both the dosimetry for A-bomb survivor data and the choice of mathematical models for extrapolating risk from high to low doses. Nevertheless, much can be learned about the nature of the health risks by reviewing the epidemiologic literature. We present a summary of diseases which have been associated with low-LET radiation (less than 1000 rad) in at least two independent studies, according to the mean cumulative organ dose at which the disease was observed. At organ doses of less than or equal to 50 rad, the only diseases that have been reported consistently are thyroid cancer, salivary gland tumors, and leukemia. The first two diseases were observed in association with x-ray epilation of the scalp for tinea capitis, a therapy which is no longer employed. On the other hand, leukemia has been observed repeatedly to occur at cumulative doses of greater than or equal to 30 rad low-LET radiation.

Entities:  

Mesh:

Year:  1982        PMID: 7041660      PMCID: PMC1650115          DOI: 10.2105/ajph.72.6.585

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  29 in total

1.  Breast neoplasms in women treated with x-rays for acute postpartum mastitis.

Authors:  R E Shore; L H Hempelmann; E Kowaluk; P S Mansur; B S Pasternack; R E Albert; G E Haughie
Journal:  J Natl Cancer Inst       Date:  1977-09       Impact factor: 13.506

2.  Breast neoplasms in women treated with x rays for acute postpartum mastitis. A pilot study.

Authors:  F A Mettler; L H Hempelmann; A M Dutton; J W Pifer; E T Toyooka; W R Ames
Journal:  J Natl Cancer Inst       Date:  1969-10       Impact factor: 13.506

3.  Breast cancer following multiple fluoroscopies during artificial pneumothorax treatment of pulmonary tuberculosis.

Authors:  J A Myrden; J E Hiltz
Journal:  Can Med Assoc J       Date:  1969-06-14       Impact factor: 8.262

4.  Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis.

Authors:  W M Brown; R Doll
Journal:  Br Med J       Date:  1965-12-04

5.  The shape of the dose-response curve for radiation carcinogenesis. Extrapolation to low doses.

Authors:  J M Brown
Journal:  Radiat Res       Date:  1977-07       Impact factor: 2.841

6.  The question of radiation causation of cancer in Hanford workers.

Authors:  J W Gofman
Journal:  Health Phys       Date:  1979-11       Impact factor: 1.316

7.  Estimation of breast doses and breast cancer risk associated with repeated fluoroscopic chest examinations of women with tuberculosis.

Authors:  J D Boice; M Rosenstein; E D Trout
Journal:  Radiat Res       Date:  1978-02       Impact factor: 2.841

8.  A dosage response curve for the one rad range: adult risks from diagnostic radiation.

Authors:  I D Bross; M Ball; S Falen
Journal:  Am J Public Health       Date:  1979-02       Impact factor: 9.308

9.  Breast cancer following irradiation of the breast.

Authors:  E Baral; L E Larsson; B Mattsson
Journal:  Cancer       Date:  1977-12       Impact factor: 6.860

10.  Late effects of x irradiation in patients treated for metropathia haemorrhagica.

Authors:  P G Smith; R Doll
Journal:  Br J Radiol       Date:  1976-03       Impact factor: 3.039

View more
  2 in total

1.  Long-Term Effects of Exposure to Ionizing Irradiation on Periodontal Health Status - The Tinea capitis Cohort Study.

Authors:  Siegal Sadetzki; Angela Chetrit; Harold D Sgan-Cohen; Jonathan Mann; Tova Amitai; Hadas Even-Nir; Yuval Vered
Journal:  Front Public Health       Date:  2015-10-19

2.  Caries Experience among Adults Exposed to Low to Moderate Doses of Ionizing Radiation in Childhood - The Tinea Capitis Cohort.

Authors:  Yuval Vered; Angela Chetrit; Harold D Sgan-Cohen; Tova Amitai; Jonathan Mann; Hadas Even-Nir; Siegal Sadetzki
Journal:  Front Public Health       Date:  2016-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.